Welcome to LookChem.com Sign In|Join Free
  • or
(E)-1-(6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)-N-hydroxymethanimine is a bicyclic chemical compound with the molecular formula C11H17NO. It features a hydroxymethanimine group and a bicyclo[3.1.1]heptene moiety, with a trans configuration. This colorless liquid at room temperature is utilized in organic synthesis and has potential applications in coordination chemistry due to its ability to act as a ligand. Additionally, it has shown promise in medicinal properties, such as anti-inflammatory and neuroprotective effects, making it a compound of interest for further research and development.

2111-71-9

Post Buying Request

2111-71-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2111-71-9 Usage

Uses

Used in Organic Synthesis:
(E)-1-(6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)-N-hydroxymethanimine is used as a key intermediate in the synthesis of various organic compounds. Its unique bicyclic structure and functional groups make it a valuable building block for creating complex molecules with specific properties and applications.
Used as a Ligand in Coordination Chemistry:
In coordination chemistry, (E)-1-(6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)-N-hydroxymethanimine is used as a ligand to form coordination complexes with metal ions. These complexes can exhibit unique chemical and physical properties, which can be exploited in various applications, such as catalysis, sensing, and materials science.
Used in Medicinal Chemistry:
(E)-1-(6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)-N-hydroxymethanimine is used as a starting material or a structural component in the development of new pharmaceuticals. Its demonstrated anti-inflammatory and neuroprotective effects make it a promising candidate for the treatment of various diseases and conditions, including inflammation-related disorders and neurodegenerative diseases.
Used in Pharmaceutical Research and Development:
In the pharmaceutical industry, (E)-1-(6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)-N-hydroxymethanimine is used as a molecule of interest for further research and development. Its potential medicinal properties, along with its unique chemical structure, make it a valuable compound for exploring new therapeutic approaches and developing innovative drugs.

Check Digit Verification of cas no

The CAS Registry Mumber 2111-71-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,1,1 and 1 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 2111-71:
(6*2)+(5*1)+(4*1)+(3*1)+(2*7)+(1*1)=39
39 % 10 = 9
So 2111-71-9 is a valid CAS Registry Number.

2111-71-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name (NE)-N-[(6,6-dimethyl-4-bicyclo[3.1.1]hept-3-enyl)methylidene]hydroxylamine

1.2 Other means of identification

Product number -
Other names myrtenal oxime

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2111-71-9 SDS

2111-71-9Relevant academic research and scientific papers

Ruthenium-catalyzed rearrangement of aldoximes to primary amides in water

Garcia-Alvarez, Rocio,Diaz-Alvarez, Alba E.,Borge, Javier,Crochet, Pascale,Cadierno, Victorio

, p. 6482 - 6490 (2012/10/30)

The rearrangement of aldoximes to primary amides has been studied using the readily available arene-ruthenium(II) complex [RuCl2(η 6-C6Me6){P(NMe2)3}] (5 mol %) as catalyst. Reactions proceeded cleanly in pure water at 100 °C without the assistance of any cocatalyst, affording the desired amides in high yields (70-90%) after short reaction times (1-7 h). The process was operative with both aromatic, heteroaromatic, α,β-unsaturated, and aliphatic aldoximes and tolerated several functional groups. Reaction profiles and experiments using 18O-labeled water indicate that two different mechanisms are implicated in these transformations. In both of them, nitrile intermediates are initially formed by dehydration of the aldoximes. These intermediates are then hydrated to the corresponding amides by the action of a second molecule of aldoxime or water. A kinetic analysis of the rearrangement of benzaldoxime to benzamide is also discussed.

Syntheses of new chiral phosphane ligands by diastereoselective conjugate addition of phosphides to enantiomerically pure acceptor-substituted olefins from the chiral pool

Wiese, Burkhard,Knuehl, Guido,Flubacher, Dietmar,Priess, Jan W.,Ulriksen, Bolette,Broedner, Kerstin,Helmchen, Guenter

, p. 3246 - 3262 (2007/10/03)

A variety of new chiral phosphanes were prepared by highly diastereoselective additions of phosphanes to α,β-unsaturated carbonyl compounds and related acceptor-substituted olefins derived from myrtenal as ex chiral pool source. Monophosphanes with astereogenic as well as stereogenic phosphorus are described. In addition diphosphanes were prepared by a highly diastereoselective double conjugate addition of a secondary diphosphane. Wiley-VCH Verlag GmbH & Co. KGaA, 2005.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 2111-71-9